Trang kết quả 31 cho Khu vực: Chăm sóc sức khỏe Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (2520)
- Argentina (22)
- Úc (185)
- Áo (85)
- Bỉ (15)
- Brazil (96)
- Canada (378)
- Chile (9)
- Trung Quốc (423)
- Cộng hòa Séc (1)
- Đan Mạch (17)
- Phần Lan (18)
- Pháp (96)
- Đức (1842)
- Hy Lạp (4)
- Hồng Kông (190)
- Hungary (2)
- Ấn Độ (227)
- Indonesia (25)
- Ai-len (4)
- Israel (56)
- Ý (30)
- Nhật Bản (212)
- Malaysia (26)
- Mexico (109)
- Hà Lan (4)
- New Zealand (17)
- Na Uy (27)
- Ba Lan (24)
- Qatar (2)
- Nga (7)
- Singapore (34)
- Nam Phi (13)
- Hàn Quốc (66)
- Tây Ban Nha (13)
- Suriname (9)
- Thụy Điển (166)
- Thụy Sĩ (39)
- Đài Loan (179)
- Thái Lan (68)
- Thổ Nhĩ Kỳ (13)
- Vương quốc Anh (220)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (4)
- Aquis AQSE (1)
- ASX (185)
- Athens (4)
- Brussels (15)
- BSE (107)
- Budapest (2)
- Buenos Aires (22)
- Canadian Sec (195)
- Cboe CA (10)
- Copenhagen (17)
- Dusseldorf (5)
- Frankfurt (1603)
- Hamburg (3)
- Helsinki (18)
- HKSE (190)
- IOB (106)
- Irish (4)
- Istanbul (13)
- Jakarta (25)
- Johannesburg (13)
- KSE (66)
- Kuala Lumpur (26)
- LSE (113)
- MCE (13)
- MCX (7)
- Mexico (109)
- Milan (30)
- Munich (52)
- NasdaqCM (455)
- NasdaqGM (217)
- NasdaqGS (392)
- NEO (1)
- NSE (120)
- NYSE (127)
- NYSE American (39)
- NZSE (17)
- Oslo (27)
- Other OTC (1290)
- Paris (96)
- Prague (1)
- Qatar (2)
- Riga (1)
- Santiago (9)
- São Paulo (96)
- Sapporo (3)
- Saudi (9)
- SES (34)
- Shanghai (190)
- Shenzhen (233)
- Stockholm (166)
- Stuttgart (77)
- Swiss (39)
- Taipei Exchange (149)
- Taiwan (30)
- Tel Aviv (56)
- Thailand (68)
- Tokyo (209)
- Toronto (70)
- TSXV (102)
- Vienna (85)
- Warsaw (24)
- XETRA (102)
Chăm sóc sức khỏe (7776)
Tất cả các ngành
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2608)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1702)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (554)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (420)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (502)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Golden Developing DVLP | $0.0001 — |
+9900
|
$141.35K — | $500K — | $0.0001 — | $0.0001 — | $141.35K — | 0 | $0 — | |
| Priority Aviation PJET | $0.0001 — |
0
|
$98.01K — | $15.4K — | $0.0001 — | $0.0001 — | $98.01K — | 0 | -$0.16 — | |
| Predictive Technology PRED | $0.0001 — |
0
|
$89.88K — | $100 — | $0.0001 — | $0.0001 — | $89.88K — | 0 | -$0.08 — | |
| Pharnext S.C.A. ALPHA.PA | $0.01 0.01 USD |
-22.89
|
$78.27K 85.56K USD | $1.36M 1.49M USD | $0.01 0.01 USD | $0.02 0.02 USD | $78.27K 85.56K USD | 0 | -$200 -218.6 USD | |
| NxGen Brands NXGB | $0.0035 — |
0
|
$73.78K — | $999 — | $0.0002 — | $0.0002 — | $73.78K — | 0 | $0 — | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $2.34M — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Amarantus BioScience AMBS | $0.0001 — |
0
|
$63.04K — | $68K — | $0.0001 — | $0.0001 — | $63.04K — | 0 | -$0.01 — | |
| Calithera Biosciences CALA | $0.01 — |
0
|
$60.91K — | $100 — | $0.01 — | $0.01 — | $60.91K — | 0 | -$7.94 — | |
| Bloomios BLMS | $0.0008999 — |
0
|
$58.03K — | $100K — | $0.0008999 — | $0.0008999 — | $58.03K — | 0 | -$1.86 — | |
| Neurobiological NTII | $0 — |
0
|
$54.31K — | $1.1K — | $0 — | $0 — | $54.31K — | 0 | $0 — | |
| National Healthcare Logistics NHLG | $0.002 — |
0
|
$50.55K — | $20K — | $0.002 — | $0.002 — | $50.55K — | 0 | $0 — | |
| Statera Biopharma STAB | $0.0005999 — |
0
|
$42.85K — | $85.23K — | $0.0005999 — | $0.0005999 — | $42.85K — | 0 | -$2.36 — | |
| For The Earth FTEG | $0 — |
0
|
$37.02K — | $250K — | $0 — | $0 — | $37.02K — | 0 | $0 — | |
| Bhang BHNGF | $0 — |
0
|
$35.58K — | $10 — | $0 — | $0 — | $35.58K — | 0 | -$0.02 — | |
| MagForce AG MF6.SG | $0.001 0.0010 USD |
0
|
$29.93K 32.72K USD | $2.47K 2.69K USD | $0.001 0.0010 USD | $0.0015 0.0016 USD | $29.93K 32.72K USD | 0 | -$0.35 -0.3 USD | |
| Hemp HEMP | $0 — |
0
|
$23.74K — | $1.53M — | $0 — | $0 — | $23.74K — | 0 | $0 — | |
| Amazonas Florestal AZFL | $0 — |
0
|
$16.41K — | $50K — | $0 — | $0 — | $16.41K — | 0 | $0 — | |
| Regenicin RGIN | $0.0001 — |
0
|
$15.35K — | $15K — | $0.0001 — | $0.0001 — | $15.35K — | 0 | -$0.01 — | |
| Neovacs S.A. ALNEV.PA | $0.02999 0.03 USD |
-1.67
|
$13.77K 15.05K USD | $224.53K 245.44K USD | $0.02999 0.03 USD | $0.02999 0.03 USD | $13.77K 15.05K USD | 0 | -$24.85 -27.1 USD | |
| Q BioMed QBIO | $0.0001 — |
0
|
$14.51K — | $12.38K — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Item 9 Labs INLB | $0.0001 — |
0
|
$10.24K — | $56.5K — | $0 — | $0.0001 — | $10.24K — | 0 | -$0.33 — | |
| Adhera Therapeutics ATRX | $0.0011 — |
0
|
$7.94K — | $100 — | $0.0011 — | $0.0011 — | $7.94K — | 0 | -$1.17 — | |
| BioLife Sciences BLFE | $0 — |
0
|
$3.18K — | $50 — | $0 — | $0 — | $3.18K — | 0 | -$0.04 — | |
| Patient Access PASO | $0 — |
0
|
$2.48K — | $1K — | $0 — | $0 — | $2.48K — | 0 | $0 — | |
| Omnimmune OMMH | $0.0001 — |
+49.25
|
$980 — | $169.07K — | $0.0001 — | $0.0001 — | $980 — | 0 | -$0.2 — | |
| Cannabis Strategic Ventures NUGS | $0 — |
-99
|
$368 — | $5K — | $0 — | $0 — | $368 — | 0 | $0 — | |
| SpectraScience SCIE | $0 — |
0
|
$223 — | $10K — | $0 — | $0 — | $223 — | 0 | -$0.01 — | |
| Safe Orthopaedics SA ALSAF.PA | $0.0004 0.00043 USD |
+100
|
$153 167.25 USD | $62.58M 68.41M USD | $0.0002 0.00021 USD | $0.0005999 0.00065 USD | $153 167.25 USD | 0 | -$286.6 -313.4 USD | |
| Global WholeHealth Partners GWHP | $0 — |
0
|
$131 — | $103.3K — | $0 — | $0 — | $131 — | 0 | -$0.05 — | |
| Rebus RBSH | $0 — |
-99
|
$32 — | $3.86K — | $0 — | $0.0001 — | $32 — | 0.000050 | $0.02 — | |
| The Flowr FLWPF | $0 — |
0
|
$0 — | $200 — | $0 — | $0 — | $0 — | 0 | $0 — | |
| NLS Pharmaceutics NLSPW | $0.02999 — |
-22.25
|
$0 — | $10.03K — | $0.02999 — | $0.04 — | $0 — | 0 | $0 — | |
| enVVeno Medical NVNOW | $0.0063 — |
-32.98
|
$0 — | $24.25K — | $0.006 — | $0.01 — | $0 — | 0 | -$1.9 — | |
| Callitas Health MPHMF | $0.0001 — |
+9900
|
$0 — | $19.57K — | $0.0001 — | $0.0001 — | $0 — | 0 | $0 — | |
| Clever Leaves CLVRW | $0.02 — |
0
|
$0 — | $250 — | $0.02 — | $0.02 — | $0 — | 0 | $0 — | |
| Implantica AG IMP-A-SDB.ST | $29.6 2.89 USD |
-0.84
|
$0 0 USD | $26.93K 2.63K USD | $29 2.83 USD | $30.1 2.94 USD | $0 0 USD | 0 | -$0.06 -0.006 USD | |
| Orpea SA OPA0.F | $6.8 7.43 USD |
0
|
$4.45T 4.86T USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.45T 4.86T USD | 0 | $0 0 USD | |
| Eli Lilly and Company LLY.BA | $21,043 24.87 USD |
+4.48
|
$897.61T 1.06T USD | $1.96K 2.32 USD | $20,250 23.94 USD | $21,130 24.98 USD | $897.61T 1.06T USD | 0.85 | $24.6K 29.08 USD | |
| Eli Lilly and Company LILY34.SA | $164.09 33.26 USD |
0
|
$4.68T 948.27B USD | $16.74K 3.39K USD | $159.51 32.33 USD | $164.09 33.26 USD | $4.68T 948.27B USD | 133.40 | $1.23 0.25 USD | |
| Eli Lilly and Company LLY.MX | $16,071.01 951.6 USD |
-0.64
|
$15.43T 913.6B USD | $206 12.2 USD | $16,071.01 951.6 USD | $16,071.01 951.6 USD | $15.43T 913.6B USD | 128.20 | $125.35 7.42 USD | |
| Eli Lilly and Company LLY.F | $830.2 907.52 USD |
+0.61
|
$789.03B 862.51B USD | $434 474.42 USD | $824.1 900.85 USD | $833.8 911.46 USD | $789.03B 862.51B USD | 131.56 | $6.31 6.9 USD | |
| Eli Lilly and Company LLY.DE | $827.7 904.79 USD |
-1.67
|
$786.65B 859.91B USD | $2.34K 2.55K USD | $821.8 898.34 USD | $832 909.49 USD | $786.65B 859.91B USD | 129.93 | $6.37 6.96 USD | |
| Eli Lilly and Company LLYC.VI | $827.1 904.13 USD |
-1.62
|
$786.08B 859.29B USD | $19 20.77 USD | $825.4 902.27 USD | $827.7 904.79 USD | $786.08B 859.29B USD | 131.49 | $6.29 6.88 USD | |
| Eli Lilly and Company LLY.SW | $790 898.85 USD |
0
|
$750.82B 854.27B USD | $32 36.41 USD | $790 898.85 USD | $800 910.23 USD | $750.82B 854.27B USD | 131.66 | $6 6.83 USD | |
| Novo Nordisk A/S N1VO34.SA | $96.51 19.56 USD |
+0.09
|
$3.45T 698.27B USD | $1.83K 370.91 USD | $96.17 19.49 USD | $97.01 19.66 USD | $3.45T 698.27B USD | 6.19 | $15.59 3.16 USD | |
| Novo Nordisk A/S NOVA.F | $133 145.39 USD |
+1.14
|
$592.37B 647.54B USD | $1.22K 1.34K USD | $131.5 143.75 USD | $133 145.39 USD | $592.37B 647.54B USD | 49.81 | $2.67 2.92 USD | |
| UnitedHealth Group Incorporated UNHH34.SA | $37.68 7.64 USD |
-0.21
|
$2.43T 492.04B USD | $130.93K 26.54K USD | $37.51 7.6 USD | $37.8 7.66 USD | $2.43T 492.04B USD | 29.43 | $1.28 0.26 USD | |
| UnitedHealth Group Incorporated UNH.MX | $8,788.54 520.39 USD |
-1.18
|
$8.16T 483.06B USD | $1.91K 113.21 USD | $8,788.54 520.39 USD | $8,851.4 524.11 USD | $8.16T 483.06B USD | 29.23 | $300.57 17.8 USD | |
| UnitedHealth Group Incorporated UNH.F | $449.9 491.8 USD |
+0.18
|
$414.88B 453.53B USD | $20 21.86 USD | $445.95 487.48 USD | $455.05 497.43 USD | $414.88B 453.53B USD | 29.40 | $15.3 16.72 USD | |
| UnitedHealth Group Incorporated UNH.DE | $450.6 492.57 USD |
+0.31
|
$414.88B 453.52B USD | $1.38K 1.51K USD | $444.9 486.34 USD | $456.7 499.23 USD | $414.88B 453.52B USD | 29.41 | $15.32 16.75 USD | |
| UnitedHealth Group Incorporated UNH.VI | $450.2 492.13 USD |
+0.28
|
$414.88B 453.52B USD | $0 0 USD | $450.2 492.13 USD | $452.7 494.86 USD | $414.88B 453.52B USD | 29.50 | $15.26 16.68 USD | |
| UnitedHealth Group Incorporated UNH.SN | $487.16 — |
0
|
$448.37B — | $0 — | $487.16 — | $487.16 — | $448.37B — | 29.75 | $16.37 — | |
| Johnson & Johnson JNJ.BA | $12,579 14.87 USD |
+2.26
|
$337.73T 399.21B USD | $2.04K 2.41 USD | $12,260 14.49 USD | $12,600 14.89 USD | $337.73T 399.21B USD | 10.32 | $1.22K 1.44 USD | |
| Johnson & Johnson JNJB34.SA | $54.07 10.96 USD |
+0.35
|
$1.95T 395.84B USD | $7.09K 1.44K USD | $53.38 10.82 USD | $54.1 10.97 USD | $1.95T 395.84B USD | 22.06 | $2.45 0.5 USD | |
| Johnson & Johnson JNJ.MX | $2,702.99 160.05 USD |
+0.44
|
$6.58T 389.34B USD | $41 2.43 USD | $2,691.02 159.34 USD | $2,703.1 160.06 USD | $6.58T 389.34B USD | 21.88 | $123.53 7.31 USD | |
| AstraZeneca PLC AZN.BA | $49,830 58.9 USD |
+0.43
|
$317.42T 375.2B USD | $134 0.16 USD | $47,100 55.67 USD | $49,850 58.92 USD | $317.42T 375.2B USD | 938.94 | $53.07 0.06 USD | |
| Merck & Co., Inc. MRCK34.SA | $88.35 17.91 USD |
+0.34
|
$1.81T 366.09B USD | $522 105.8 USD | $88.1 17.86 USD | $88.79 18 USD | $1.81T 366.09B USD | 144.83 | $0.61 0.12 USD | |
| Johnson & Johnson JNJ.F | $138.5 151.4 USD |
+0.13
|
$334.39B 365.54B USD | $556 607.78 USD | $137.82 150.66 USD | $138.56 151.46 USD | $334.39B 365.54B USD | 22.01 | $6.29 6.88 USD | |
| Johnson & Johnson JNJ.DE | $138.86 151.79 USD |
+2.09
|
$334.39B 365.54B USD | $4.92K 5.37K USD | $137.54 150.35 USD | $139.42 152.4 USD | $334.39B 365.54B USD | 22.07 | $6.29 6.88 USD | |
| Johnson & Johnson JNJ.VI | $138.88 151.81 USD |
+1.97
|
$334.39B 365.53B USD | $120 131.18 USD | $137.86 150.7 USD | $138.88 151.81 USD | $334.39B 365.53B USD | 22.18 | $6.26 6.84 USD | |
| Merck & Co., Inc. MRK.MX | $2,364.2 139.99 USD |
+0.28
|
$6.08T 360.08B USD | $19 1.13 USD | $2,364.2 139.99 USD | $2,364.2 139.99 USD | $6.08T 360.08B USD | 142.85 | $16.55 0.98 USD | |
| Merck & Co., Inc. MRK.BA | $32,500 38.42 USD |
+0.56
|
$304.15T 359.51B USD | $19 0.02 USD | $32,500 38.42 USD | $32,900 38.89 USD | $304.15T 359.51B USD | 3.98 | $8.15K 9.64 USD | |
| Novo Nordisk A/S NVON.MX | $2,575 152.47 USD |
-0.96
|
$5.94T 351.62B USD | $481 28.48 USD | $2,525.41 149.54 USD | $2,649.59 156.89 USD | $5.94T 351.62B USD | 41.47 | $62.09 3.68 USD | |
| Johnson & Johnson JNJ.SN | $145.55 — |
-1.83
|
$351.43B — | $0 — | $145.55 — | $145.55 — | $351.43B — | 21.62 | $6.73 — | |
| Merck & Co., Inc. MRK.VI | $121 132.27 USD |
+0.5
|
$309.26B 338.06B USD | $0 0 USD | $121 132.27 USD | $121.2 132.49 USD | $309.26B 338.06B USD | 145.78 | $0.83 0.91 USD | |
| Merck & Co., Inc. 6MK.DE | $121.2 132.49 USD |
+0.5
|
$309.26B 338.06B USD | $490 535.64 USD | $120.8 132.05 USD | $122 133.36 USD | $309.26B 338.06B USD | 144.28 | $0.84 0.92 USD | |
| Merck & Co., Inc. 6MK.F | $120.6 131.83 USD |
+0.84
|
$309.26B 338.06B USD | $4 4.37 USD | $120.6 131.83 USD | $120.8 132.05 USD | $309.26B 338.06B USD | 143.57 | $0.84 0.92 USD | |
| AbbVie Inc. ABBV34.SA | $57.96 11.75 USD |
-1.73
|
$1.64T 332.7B USD | $488 98.91 USD | $57.47 11.65 USD | $58.98 11.95 USD | $1.64T 332.7B USD | 50.39 | $1.15 0.23 USD | |
| Merck & Co., Inc. MRK.SN | $127.84 — |
0
|
$331.09B — | $0 — | $127.84 — | $127.84 — | $331.09B — | 143.64 | $0.89 — | |
| AbbVie Inc. ABBV.MX | $3,103.11 183.74 USD |
-1.99
|
$5.53T 327.23B USD | $1.11K 65.67 USD | $3,103.11 183.74 USD | $3,103.11 183.74 USD | $5.53T 327.23B USD | 50.25 | $61.75 3.66 USD | |
| AbbVie Inc. 4AB.DE | $160.02 174.92 USD |
-0.29
|
$282.57B 308.89B USD | $478 522.52 USD | $158.98 173.79 USD | $161 175.99 USD | $282.57B 308.89B USD | 50.96 | $3.14 3.43 USD | |
| AbbVie Inc. ABBV.VI | $159.78 174.66 USD |
-0.13
|
$282.15B 308.43B USD | $0 0 USD | $159.78 174.66 USD | $160.64 175.6 USD | $282.15B 308.43B USD | 51.04 | $3.13 3.42 USD | |
| AbbVie Inc. 4AB.F | $159.7 174.57 USD |
-0.27
|
$282.01B 308.27B USD | $18 19.68 USD | $159.7 174.57 USD | $161.4 176.43 USD | $282.01B 308.27B USD | 50.69 | $3.15 3.44 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC A1ZN34.SA | $71.69 14.53 USD |
+0.83
|
$1.34T 270.64B USD | $3.46K 701.29 USD | $71.1 14.41 USD | $71.85 14.56 USD | $1.34T 270.64B USD | 19.48 | $3.68 0.75 USD | |
| AstraZeneca PLC AZNN.MX | $1,435 84.97 USD |
0
|
$4.5T 266.2B USD | $673 39.85 USD | $1,435 84.97 USD | $1,435 84.97 USD | $4.5T 266.2B USD | 38.60 | $37.17 2.2 USD | |
| AstraZeneca PLC AZNCF | $156.55 — |
0
|
$251.78B — | $139 — | $156.55 — | $156.55 — | $251.78B — | 38.75 | $4.04 — | |
| AstraZeneca PLC ZEG.F | $147.95 161.73 USD |
+0.82
|
$229.36B 250.72B USD | $237 259.07 USD | $146.45 160.09 USD | $147.95 161.73 USD | $229.36B 250.72B USD | 39.03 | $3.79 4.14 USD | |
| AstraZeneca PLC ZEGA.F | $73 79.8 USD |
0
|
$228.63B 249.92B USD | $50 54.66 USD | $73 79.8 USD | $73 79.8 USD | $228.63B 249.92B USD | 38.62 | $1.89 2.07 USD | |
| Roche Holding AG ROGN.MX | $5,345.37 316.51 USD |
0
|
$4.2T 248.81B USD | $552 32.69 USD | $5,345.37 316.51 USD | $5,345.37 316.51 USD | $4.2T 248.81B USD | 18.14 | $294.53 17.44 USD | |
| Novartis AG NVS.BA | $32,702 38.65 USD |
-1.5
|
$205.26T 242.62B USD | $49 0.06 USD | $32,702 38.65 USD | $33,200 39.24 USD | $205.26T 242.62B USD | 4.10 | $7.97K 9.42 USD | |
| Thermo Fisher Scientific Inc. TMO.BA | $34,058.5 40.26 USD |
+5
|
$203.76T 240.85B USD | $1 0 USD | $34,058.5 40.26 USD | $34,058.5 40.26 USD | $203.76T 240.85B USD | 2.41 | $14.12K 16.69 USD | |
| Thermo Fisher Scientific Inc. TMOS34.SA | $64.09 12.99 USD |
+1.34
|
$1.18T 238.3B USD | $45.82K 9.29K USD | $63.77 12.93 USD | $64.53 13.08 USD | $1.18T 238.3B USD | 36.20 | $1.77 0.36 USD | |
| Novartis AG N1VS34.SA | $57.19 11.59 USD |
-0.82
|
$1.17T 237.83B USD | $2 0.41 USD | $57.19 11.59 USD | $57.48 11.65 USD | $1.17T 237.83B USD | 2.38 | $24 4.86 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Thermo Fisher Scientific Inc. TMO.MX | $10,271.09 608.17 USD |
+0.54
|
$3.96T 234.39B USD | $303 17.94 USD | $10,237.58 606.19 USD | $10,271.09 608.17 USD | $3.96T 234.39B USD | 35.84 | $286.56 16.97 USD | |
| Novartis AG NVSN.MX | $1,851.08 109.61 USD |
0
|
$3.95T 233.93B USD | $0 0 USD | $1,851.08 109.61 USD | $1,851.08 109.61 USD | $3.95T 233.93B USD | 22.88 | $80.89 4.79 USD | |
| Roche Holding AG RHO6.F | $33.2 36.29 USD |
+2.45
|
$213.69B 233.59B USD | $500 546.57 USD | $32.16 35.15 USD | $33.2 36.29 USD | $213.69B 233.59B USD | 17.75 | $1.87 2.04 USD | |
| Roche Holding AG RHHBF | $299.3 — |
+1.36
|
$233.55B — | $300 — | $299.3 — | $299.3 — | $233.55B — | 18.49 | $16.18 — | |
| Thermo Fisher Scientific Inc. TMOF.VI | $529.8 579.14 USD |
+2.3
|
$202.23B 221.07B USD | $0 0 USD | $529.8 579.14 USD | $529.8 579.14 USD | $202.23B 221.07B USD | 36.48 | $14.52 15.87 USD | |
| Thermo Fisher Scientific Inc. TN8.DE | $529.3 578.6 USD |
+2.2
|
$202.04B 220.86B USD | $40 43.73 USD | $516.6 564.71 USD | $531.4 580.89 USD | $202.04B 220.86B USD | 36.35 | $14.56 15.92 USD | |
| Thermo Fisher Scientific Inc. TN8.F | $522.1 570.73 USD |
-0.7
|
$201.31B 220.06B USD | $48 52.47 USD | $518.7 567.01 USD | $522.1 570.73 USD | $201.31B 220.06B USD | 35.83 | $14.57 15.93 USD | |
| Novartis AG NOTA.F | $97 106.03 USD |
-0.21
|
$200.91B 219.63B USD | $1 1.09 USD | $97 106.03 USD | $97 106.03 USD | $200.91B 219.63B USD | 23.60 | $4.11 4.49 USD | |
| Danaher Corporation DHER34.SA | $49.4 10.01 USD |
+2.09
|
$1.03T 208.81B USD | $42.58K 8.63K USD | $48.39 9.81 USD | $49.4 10.01 USD | $1.03T 208.81B USD | 46.60 | $1.06 0.21 USD | |
| Danaher Corporation DHR.MX | $4,602.53 272.53 USD |
+2.76
|
$3.47T 205.38B USD | $344 20.37 USD | $4,518.7 267.56 USD | $4,613.31 273.16 USD | $3.47T 205.38B USD | 46.08 | $99.87 5.91 USD | |
| Abbott Laboratories ABT.BA | $33,192.5 39.23 USD |
+1
|
$172.4T 203.79B USD | $74 0.09 USD | $31,650 37.41 USD | $33,233 39.28 USD | $172.4T 203.79B USD | 5.70 | $5.81K 6.87 USD | |
| Abbott Laboratories ABTT34.SA | $47.75 9.68 USD |
-0.6
|
$1T 203.36B USD | $101 20.47 USD | $47.75 9.68 USD | $47.85 9.7 USD | $1T 203.36B USD | 32.70 | $1.46 0.3 USD | |
| Abbott Laboratories ABT.MX | $1,917 113.51 USD |
-0.47
|
$3.38T 200.02B USD | $22 1.3 USD | $1,917 113.51 USD | $1,917 113.51 USD | $3.38T 200.02B USD | 32.46 | $59.04 3.5 USD | |
| Abbott Laboratories ABT.SN | $111.55 — |
-0.77
|
$194.06B — | $0 — | $111.55 — | $111.55 — | $194.06B — | 34.75 | $3.21 — | |
| Danaher Corporation DHRC.VI | $236.75 258.8 USD |
+2.33
|
$176.39B 192.82B USD | $0 0 USD | $236.75 258.8 USD | $236.75 258.8 USD | $176.39B 192.82B USD | 46.69 | $5.07 5.54 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||